From: Prognostic significance of diabetes mellitus in locally advanced non-small cell lung cancer
 |  | DM (−) | DM (+) | p value |
---|---|---|---|---|
Gender | Male | 98 | 28 | 0.01 a |
 | Female | 31 | 2 |  |
Age, median (range) |  | 64 (40–75) | 64.5 (49–74) | 0.44b |
Performance status | 0 | 72 | 18 | 0.51a |
 | 1 | 56 | 11 |  |
 | 2 | 1 | 1 |  |
Stage | IIIA | 70 | 16 | 0.92a |
 | IIIB | 59 | 14 |  |
Histology | Adenocarcinoma | 71 | 16 | 0.76a |
 | Squamous cell carcinoma | 45 | 9 |  |
 | Large cell carcinoma | 4 | 2 |  |
 | Others | 9 | 3 |  |
Smoking history | Current or former | 95 | 24 | 0.22a |
 | Never | 23 | 2 |  |
 | Unknown | 11 | 4 |  |
Body mass index (BMI) (kg/m2) | BMI < 18.5 | 13 | 2 | 0.69a |
 | 18.5 ≤ BMI <25 | 94 | 22 |  |
 | 25 ≤ BMI < 30 | 20 | 6 |  |
 | BMI ≥ 30 | 2 | 0 |  |
Laboratory parameters, median | Â | Â | Â | b |
 | White blood cell, cells/μl | 7060 (2950–22310) | 7275 (4290–13580) | 0.67 |
 | Hemoglobin, g/l | 13.4 (8.7–17.2) | 13.6 (7.2–16.0) | 0.49 |
 | Albumin, g/dl | 4.1 (2.4–4.8) | 4.0 (3.2–4.9) | 0.71 |
 | AST, U/l | 20 (11–60) | 20.5 (11–50) | 0.32 |
 | ALT, U/l | 18 (5–67) | 22.5 (9–63) | 0.16 |
 | LDH, U/l | 187 (121–591) | 208 (135–1120) | 0.05 |
 | Calcium, mg/dl | 9.0 (7.6–10.6) | 9.05 (8.2–9.9) | 0.59 |
 | Creatinine, mg/dl | 0.71 (0.4–1.28) | 0.73 (0.48–1.23) | 0.43 |
 | Glucose, mg/dl | 100 (62–144) | 118 (85–230) | <0.001 |